FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases

被引:154
作者
Itoh, Nobuyuki [1 ]
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan
关键词
adipokine; biomarker; disease; FGF21; hepatokine; metabolism; myokine; stress; GROWTH-FACTOR; 21; PLASMA-CONCENTRATIONS; FIBROBLAST; FACTOR-21; FIBROBLAST-GROWTH-FACTOR-21; OBESITY; GENE;
D O I
10.3389/fendo.2014.00107
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fibroblast growth factor (FGF) family members are mostly secreted as signaling proteins with diverse functions in development and metabolism. FGF21 is a unique FGF with metabolic, but not proliferative activities. FGF21 is mostly induced by different kinds of stress and acts though FGF receptor 1c with beta-Klotho as a cofactor in an endocrine or, in parts, autocrine/paracrine manner. Hepatic FGF21 directly acts on white adipocytes to inhibit lipolysis and acts through the brain to increase systemic glucocorticoid levels and suppress physical activity in response to starvation. It also protects against dioxin toxicity. Adipocytic FGF21 induces the browning of white adipose tissue (WAT) and activates brown adipocytes in response to cold exposure. It also acts as an upstream effector of adiponectin in white adipocytes. Myocytic FGF21 protects against diet-induced obesity and insulin resistance, induces the browning of WAT, and protects against cardiac hypertrophy. In addition, Fgf21 polymorphisms are possibly related with metabolic diseases and FGF21 are biomarker of metabolic diseases. These findings indicate that FGF21 plays roles as a hepatokine, adipokine, and myokine in metabolism, injury protection, and diseases.
引用
收藏
页数:4
相关论文
共 33 条
[1]   The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue [J].
Adams, Andrew C. ;
Yang, Chaofeng ;
Coskun, Tamer ;
Cheng, Christine C. ;
Gimeno, Ruth E. ;
Luo, Yongde ;
Kharitonenkov, Alexei .
MOLECULAR METABOLISM, 2013, 2 (01) :31-37
[2]   The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation [J].
Barbatelli, G. ;
Murano, I. ;
Madsen, L. ;
Hao, Q. ;
Jimenez, M. ;
Kristiansen, K. ;
Giacobino, J. P. ;
De Matteis, R. ;
Cinti, S. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2010, 298 (06) :E1244-E1253
[3]   FGF21 regulates metabolism and circadian behavior by acting on the nervous system [J].
Bookout, Angie L. ;
de Groot, Marleen H. M. ;
Owen, Bryn M. ;
Lee, Syann ;
Gautron, Laurent ;
Lawrence, Heather L. ;
Ding, Xunshan ;
Elmquist, Joel K. ;
Takahashi, Joseph S. ;
Mangelsdorf, David J. ;
Kliewer, Steven A. .
NATURE MEDICINE, 2013, 19 (09) :1147-1152
[4]   Fibroblast growth factor (Fgf) 21 is a novel target gene of the aryl hydrocarbon receptor (AhR) [J].
Cheng, Xingguo ;
Vispute, Saurabh G. ;
Liu, Jie ;
Cheng, Christine ;
Kharitonenkov, Alexei ;
Klaassen, Curtis D. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2014, 278 (01) :65-71
[5]   Serum Fibroblast Growth Factor-21 Levels Are Associated With Carotid Atherosclerosis Independent of Established Cardiovascular Risk Factors [J].
Chow, Wing Sun ;
Xu, Aimin ;
Woo, Yu Cho ;
Tso, Annette W. K. ;
Cheung, Stephen C. W. ;
Fong, Carol H. Y. ;
Tse, Hung Fat ;
Chau, Ming Tak ;
Cheung, Bernard M. Y. ;
Lam, Karen S. L. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (10) :2454-2459
[6]   Novel locus including FGF21 is associated with dietary macronutrient intake [J].
Chu, Audrey Y. ;
Workalemahu, Tsegaselassie ;
Paynter, Nina P. ;
Rose, Lynda M. ;
Giulianini, Franco ;
Tanaka, Toshiko ;
Ngwa, Julius S. ;
Qi, Qibin ;
Curhan, Gary C. ;
Rimm, Eric B. ;
Hunter, David J. ;
Pasquale, Louis R. ;
Ridker, Paul M. ;
Hu, Frank B. ;
Chasman, Daniel I. ;
Qi, Lu .
HUMAN MOLECULAR GENETICS, 2013, 22 (09) :1895-1902
[7]   Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease [J].
Davis, Ryan L. ;
Liang, Christina ;
Edema-Hildebrand, Fabienne ;
Riley, Catherine ;
Needham, Merrilee ;
Sue, Carolyn M. .
NEUROLOGY, 2013, 81 (21) :1819-1826
[8]   Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa [J].
Dostalova, Ivana ;
Kavalkova, Petra ;
Haluzikova, Denisa ;
Lacinova, Zdena ;
Mraz, Milos ;
Papezova, Hana ;
Haluzik, Martin .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (09) :3627-3632
[9]   Plasma Concentrations of Fibroblast Growth Factors 21 and 19 in Patients with Cushing's Syndrome [J].
Durovcova, V. ;
Marek, J. ;
Hana, V. ;
Matoulek, M. ;
Zikan, V. ;
Haluzikova, D. ;
Kavalkova, P. ;
Lacinova, Z. ;
Krsek, M. ;
Haluzik, M. .
PHYSIOLOGICAL RESEARCH, 2010, 59 (03) :415-422
[10]   FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis [J].
Fisher, Ffolliott M. ;
Kleiner, Sandra ;
Douris, Nicholas ;
Fox, Elliott C. ;
Mepani, Rina J. ;
Verdeguer, Francisco ;
Wu, Jun ;
Kharitonenkov, Alexei ;
Flier, Jeffrey S. ;
Maratos-Flier, Eleftheria ;
Spiegelman, Bruce M. .
GENES & DEVELOPMENT, 2012, 26 (03) :271-281